Member Sign In

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

Alexandria Achieves Full Pre-leasing at 100 Binney Street

Alexandria Real Estate Equities, Inc. (ARE - Free Report) announced that it has 100% pre-leased 100 Binney Street — a ground-up development project — which will provide office/laboratory space to its tenants. The building, spanning 431,000 rentable square feet (RSF) of space, is slated to be delivered in fourth-quarter 2017.

Last month, the company pre-leased 41% of the project, aggregating 175,000 RSF. This included a lease given out to Facebook to rent three floors, spanning 130,000 RSF. Alexandria has a big-box focus with respect to its tenants. Other than Facebook, the 100 Binney Street tenant roster includes some prominent life science and technology names like Bristol-Myers Squibb Company, Foghorn Therapeutics, Sigilon Therapeutics, Tango Therapeutics and TCR2 Therapeutics. The company has leased 208,000 RSF to Bristol-Myers and an aggregate of 90,000 RSF to the other four life-science companies.

Alexandria is an urban office real estate investment trust (REIT), with particular focus on AAA innovation cluster properties concentrated in urban campuses. It owns and manages 6.3 million RSF in Greater Boston, of which approximately 5.0 million RSF lies in the Cambridge market. Robust demand for best-in-class office/laboratory space in this market has resulted in high-absorption rates and accelerated the company’s internal growth.

In order to meet the elevated demand, the company is making diligent efforts to pre-lease 339 Binney Street — a Class A office/laboratory building spanning 164,000 RSF. This property is a ground-up development project located at the Alexandria Center at One Kendall Square campus. One Kendall Square is the company’s third mega campus in Cambridge, spanning 645,000 RSF. This technology and life science campus comprises nine buildings.

With vertical construction beginning soon, 339 Binney Street is scheduled to be delivered in the last quarter of 2018. Similar to 100 Binney Street, this property is expected to be fully pre-leased.

Alexandria had initially developed and modernized cluster campuses, covering more than two million square feet along the Binney Street corridor, in a bid to enhance its portfolio in the area. The company has also undertaken redevelopment programs in these campuses. In fact, it plans to add various amenities at its Alexandria Center campus. The ground floor retail space will be upgraded and prominent restaurants and eateries will also be added.

Moreover, in 2006, it acquired more than one million RSF at Technology Square, which was pivotal for Alexandria Technology Square’s redevelopment. Alexandria Technology Square was the company’s initial Cambridge-based mega campus.

Amid these encouraging efforts, Alexandria’s shares have outperformed its industry, year to date. While the stock has gained 8.4%, the industry has rallied 6% during this period. The Zacks Consensus Estimate for third-quarter 2017 funds from operations (FFO) per share inched up 0.7% to $1.50 in a month’s time.

Note: All EPS numbers presented in this write up represent funds from operations (“FFO”) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.

4 Surprising Tech Stocks to Keep an Eye On

Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really takes off.

Resources

Client Support

Follow Us

Zacks Moblie App

Zacks Research is Reported On:

Yahoo

MSN

Marketwatch

Nasdaq

Forbes

Investors.com

Morningstar

Copyright 2018 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25% per year. These returns cover a period from 1988-2017. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zack Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

Visit performance for information about the performance numbers displayed above.